[Chronic cerebrovascular diseases and metabolic syndrome: approaches to pathogenic therapy of cognitive dysfunction]

Area of Science:

• Neurology
• Vascular Medicine

Background:

• Cognitive decline is a primary symptom of chronic cerebral hypoperfusion.
• This decline leads to social disability, reduced quality of life, and impaired management of vascular pathology and comorbidities.

Purpose of the Study:

• To highlight the significance of cognitive decline in chronic cerebral hypoperfusion.
• To emphasize the need for comprehensive therapeutic strategies.

Main Methods:

• Review of existing literature on chronic cerebral hypoperfusion and cognitive decline.
• Analysis of therapeutic approaches including metabolic syndrome management and multi-action drugs.

Main Results:

• Cognitive decline significantly impacts patient outcomes and disease control.
• Therapeutic strategies must address both underlying vascular issues and associated metabolic conditions.

Conclusions:

• Pathogenetic therapy for cerebrovascular disease progression is crucial.
• Comprehensive treatment should incorporate drugs for metabolic syndrome and agents with multiple actions (hemangioma correction, antithrombotic, antioxidant, vasoactive).